Alkermes (ALKS) Other Non-Current Liabilities (2011 - 2026)
Alkermes' Other Liabilities was $204.67 million in Q3 2026, up 260.6% from $56.75 million a year earlier and up 0.2% from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
At the end of FY2025, Other Liabilities at Alkermes came in at $61.01 million, up 8.9% from FY2024.
- Other Liabilities has now increased for three consecutive years, with a five-year compound annual growth rate of 10.8% (FY2020 to FY2025).
- In earlier years, Other Liabilities was $56.02 million in FY2024 (+12.3%), $49.88 million in FY2023 (+17.7%), $42.38 million in FY2022 (-2.9%) and $43.65 million in FY2021 (+19.5%).
- The Q3 2026 figure marks the highest quarterly Other Liabilities in data going back to Q1 2013.
- Compared with a year earlier, Other Liabilities has increased for eight straight quarters, with growth averaging 99.0% over the last eight quarters.
- The best year-over-year quarter for Other Liabilities over five years was Q2 2026 (growth of 264.6%); the worst was Q4 2022 (a decline of 2.9%).
- Per Business Quant data, ALKS's Other Liabilities in the three quarters before Q3 2026 was $204.32 million (Q2 2026), $177.54 million (Q1 2026) and $61.01 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 204.67 Mn |
| Jun 30, 2026 | 204.32 Mn |
| Mar 31, 2026 | 177.54 Mn |
| Dec 31, 2025 | 61.01 Mn |
| Sep 30, 2025 | 56.75 Mn |
| Jun 30, 2025 | 56.05 Mn |
| Mar 31, 2025 | 58.85 Mn |
| Dec 31, 2024 | 56.02 Mn |
| Sep 30, 2024 | 52.63 Mn |
| Jun 30, 2024 | 48.29 Mn |
| Mar 31, 2024 | 48.96 Mn |
| Dec 31, 2023 | 49.88 Mn |
| Sep 30, 2023 | 53.62 Mn |
| Jun 30, 2023 | 48.22 Mn |
| Mar 31, 2023 | 48.49 Mn |
| Dec 31, 2022 | 42.38 Mn |
| Sep 30, 2022 | 42.86 Mn |
| Jun 30, 2022 | 45.21 Mn |
| Mar 31, 2022 | 43.91 Mn |
| Dec 31, 2021 | 43.65 Mn |
API Access
Alkermes Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();